Fidelity Investments’s PharmaCyte Biotech PMCB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Hold
0
– -$8 – 5456
2025
Q1
– Hold
0
– – – 5254
2023
Q3
– Hold
0
– -$3 – 5468
2023
Q2
– Hold
0
– – – 5329
2021
Q4
– Sell
-26
Closed -$2K – 4803
2021
Q3
$2K Buy
+26
New +$1.74K ﹤0.01% 4035

Other funds holding PMCB

Fidelity Investments's PMCB Position: Q2 2025 in Review

Fidelity Investments held its PharmaCyte Biotech (PMCB) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5456.

Fidelity Investments first reported a position in PMCB in Q3 2021 and has held it in 1 quarter since. The position peaked at $2K in Q3 2021. 17 funds tracked by Wall St. Rank hold PMCB as of Q2 2025.

  • Fidelity Investments held 0 shares of PharmaCyte Biotech worth $0 as of Q2 2025.
  • Fidelity Investments left its PharmaCyte Biotech share count unchanged in Q2 2025.
  • PharmaCyte Biotech made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2025, its #5456 holding.
  • Fidelity Investments first reported a position in PharmaCyte Biotech in Q3 2021 and has held it in 1 quarter since.
  • Fidelity Investments's PharmaCyte Biotech position peaked at $2K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held PharmaCyte Biotech as of Q2 2025.

Based on Fidelity Investments's 13F filing for Q2 2025, filed 14 Aug 2025.